πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 8 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12331334

Modified urokinase-type plasminogen activator polypeptides and methods of use

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11613744

Modified urokinase-type plasminogen activator polypeptides and methods of use

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10239954

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof fo

The Regents of the University of California Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9695249

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof

The Regents of the University of California Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9255155

Antibodies specific for urokinase-type plasminogen activator and methods of treating cance

The Regents of the University of California Β· Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029509

Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen a

The Regents of the University of California Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546322

Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

The Regents of the University of California Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects ag

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted